オハイオにおける1型糖尿病の臨床試験
オハイオ内の拠点で、1型糖尿病に関する13件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Cincinnati Children's Hospital Medical Center- Site Number : 8400018, Cincinnati
- The Ohio State University- Site Number : 8400051, Columbus
被験者募集中第3相
1歳〜25歳 · 全性別 · 2026/09/14更新 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第1/2相
12歳〜35歳 · 全性別 · 2026/09/11更新 · NCT06783309NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
被験者募集中
18歳以上 · 女性 · 2026/08/14更新 · NCT07560813Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
- Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/08/03更新 · NCT06046833Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
- Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳〜65歳 · 全性別 · 2026/07/08更新 · NCT06694558Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
被験者募集中第4相
18歳以上 · 女性 · 2026/04/29更新 · NCT07293715Kidney Precision Medicine Project
- Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/14更新 · NCT04334707Registry for Stage 2 Type 1 Diabetes
- Cincinnati Children's Hospital Medical Center- Site Number : 8400024, Cincinnati
- Rainbow Babies And Children's Hospital- Site Number : 8400011, Cleveland
- The Ohio State University- Site Number : 8400032, Columbus
被験者募集中観察研究
全年齢 · 全性別 · 2026/04/13更新 · NCT06481904Immune Function and the Progression to T1D
- The Ohio State University, Columbus
被験者募集中観察研究健康なボランティア歓迎
0歳〜100歳 · 全性別 · 2026/04/09更新 · NCT05899439Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Cleveland Clinic Foundation, Cleveland
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302Effect of C-peptide on Hypoglycemic Counterregulation
- University of Cincinnati, Cincinnati
被験者募集中早期第1相健康なボランティア歓迎
18歳〜40歳 · 全性別 · 2026/02/17更新 · NCT06470295Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中
5歳〜17歳 · 全性別 · 2025/12/04更新 · NCT07154251PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
- Ohio State University, Columbus
被験者募集中観察研究健康なボランティア歓迎
0 Days – 99 Years · 全性別 · 2023/11/21更新 · NCT06141434ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。